Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients

No abstract is available for this paper.

• Publication year

  2019

• Venue

  VirusDisease

• Publication date

  2019-01-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13337-018-00510-5PMID 31179360PMCID PMC6531556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors

  2018cited by this paper
• Epstein–Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas

  2018cited by this paper
• Human cytomegalovirus pUL97 drug-resistance mutations in congenitally neonates and HIV-infected, no-drug-treated patients

  2017cited by this paper
• Management of Antiviral Resistance in Chronic Hepatitis B

  2017cited by this paper
• Study of Genotype, Subtype and Mutation in the S Gene in Hepatitis B Patients Co-infected with HIV in Iran

  2016cited by this paper
• Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China

  2016cited by this paper
• Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones.

  2016cited by this paper
• Prediction of HBF-0259 interactions with hepatitis B Virus receptors and surface antigen secretory factors

  2016cited by this paper
• Evaluation of Biofilm Formation Among Klebsiella pneumoniae Isolates and Molecular Characterization by ERIC-PCR

  2016cited by this paper
• Incidence of natural resistance mutations in naïve chronic hepatitis B patients: A systematic review and meta‐analysis

  2015cited by this paper
• Gene Co-Expression Network Analysis Provides Novel Insights into Myostatin Regulation at Three Different Mouse Developmental Timepoints

  2015cited by this paper
• Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance

  2015cited by this paper
• HBV Carrying Drug-Resistance Mutations in Chronically Infected Treatment-Naive Patients

  2015cited by this paper
• Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients.

  2014cited by this paper
• Management of antiviral drug resistance in chronic hepatitis B.

  2014cited by this paper
• Mechanisms of Hepatitis B Virus Resistance Development

  2014cited by this paper
• MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

  2013cited by this paper
• MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

  2013cited by this paper
• Mutations in the S gene region of hepatitis B virus genotype D in Golestan Province-Iran

  2012cited by this paper
• New insight in the pathobiology of hepatitis B virus infection

  2012cited by this paper
• Predicting the functional impact of protein mutations: application to cancer genomics

  2011cited by this paper
• Large‐scale survey of naturally occurring HBV polymerase mutations associated with anti‐HBV drug resistance in untreated patients with chronic hepatitis B

  2011cited by this paper
• Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.

  2010cited by this paper
• 930 HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

  2009cited by this paper
• Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients

  2009cited by this paper
• Hepatitis B virus resistance to nucleos(t)ide analogues.

  2009cited by this paper
• HIGH RISK OF RENAL IMPAIRMENT DURING LONG-TERM ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY IN PATIENTS WITH LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B

  2009cited by this paper
• Prevalence of hepatitis B virus DNA polymerase mutations in treatment‐naïve patients with chronic hepatitis B

  2009cited by this paper
• DnaSP v5: a software for comprehensive analysis of DNA polymorphism data

  2009cited by this paper
• Chronic hepatitis B: preventing, detecting, and managing viral resistance.

  2008cited by this paper
• Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment‐naive patients

  2007cited by this paper
• Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management

  2007cited by this paper
• Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.

  2006cited by this paper
• A web-based genotyping resource for viral sequences

  2004cited by this paper
• Trial Results : Telbivudine Is Superior to Lamivudine in atients With Chronic Hepatitis B UN –

  year unknowncited by this paper
• Iranian Journal of Basic Medical Sciences Mutations in Pre-core and Basal-core Promoter Regions of Hepatitis B Virus in Chronic Hbv Patients from Golestan, Iran

  year unknowncited by this paper

• Pharmacophore modeling and QSAR analysis of anti-HBV flavonols

  2025cites this paper
• The dynamic states of hepatitis B virus capsid monomers under the impact of different class of capsid-assembly modulators

  2025cites this paper
• The Antiviral Activity of Polyphenols

  2025cites this paper
• An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action

  2024cites this paper
• Molecular Characterization and Resistance Profile of the Hepatitis B Virus to Polymerase Inhibitors in Infected Treatment-Naïve Patients in Abidjan

  2023cites this paper
• A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study

  2023cites this paper
• QSAR Modeling of a Ligand-based Pharmacophore Derived from Hepatitis B Virus Surface Antigen Inhibitors

  2021cites this paper
• Characterization of mutations in the reverse transcriptase region of hepatitis B virus in treated and untreated chronic hepatitis B patients.

  2020cites this paper
• ACTA MICROBIOLOGICA BULGARICA

  year unknowncites this paper